Article
Factor V haemostatic diathesis impairing thrombin activation, membrane binding and circulating antigen level due to a novel compound heterozygous mutation, Leu1821Ser and Gly2192Cys.
Haemophilia : the official journal of the World Federation of Hemophilia - 1 Sept 2024
Talbot Kimberley, Song Jina, Perrier John R, Jackson Shannon, MacGillivray Ross T A, Pryzdial Edward L G
Abstract excerpt
INTRODUCTION: Congenital factor V (FV) deficiency is a rare clotting disorder affecting ∼1 in 1,000,000, with bleeding severity that ranges broadly for poorly understood reasons. AIM: To help understand the molecular basis of the observed phenotype in FV deficient patients, the genetics and biochemistry causing a patient's FV deficiency were evaluated. METHODS AND RESULTS: A 71-year-old female, who had serious...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
